Monographie - Hydrocortisone

Hydrocortisone

La estabilidad de las preparaciones farmacéuticas

Factores que influyen sobre la estabilidad

Estructura química

Bibliografía : Hydrocortisone

	Tipo	Publicación
909	periódico	Chong G, Decarie D, Ensom M.H.H. Stability of hydrocortisone in extemporaneously compounded suspensions. J Informed Pharmacother 2003 ; 13: 100-110.
2538	periódico	Fawcett JP, Boulton DW, Jiang R, Woods DJ. Stability of hydrocortisone oral suspensions prepared from tablets and powder. Ann Pharmacotherapy 1995 ;29:987-990.
2835	periódico	Das Gupta V. Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Int J Pharm Compound 2007 ; 11, 3: 259-261.
3755	periódico	Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R. Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition. Int J Pharm Compound 2014 ; 18, 5: 427-431.
3810	periódico	Geiger C M, Sorenson B, Whaley P. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF. Int J Pharm Compound 2015 ; 19, 5 : 420-427.
3811	periódico	Nahata Milap C. Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures. Int J Pharm Compound 2015 ; 19, 5 : 428-431.
4063	periódico	Manchanda A, Laracy M, Savji T, Bogner R. Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension. Int J Pharm Compound 2018 ;22,1:66-75
4198	periódico	Uriel M, Gomez-Rincon C, Marro D. Stability of regularly prescribed oral liquids formulated with SyrSpend® SF. Pharmazie 2018 73;196-201
4530	periódico	Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Int J Pharm Compound 2021 ;25,5:431-439